Anti-CD20 in lupus

被引:0
|
作者
Isenberg, DA [1 ]
Leandro, MJ [1 ]
Ehrenstein, MR [1 ]
Edwards, JCW [1 ]
Manson, J [1 ]
Cambridge, G [1 ]
机构
[1] Middlesex Hosp, Ctr Rheumatol, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:27 / 28
页数:2
相关论文
共 50 条
  • [31] Effectiveness of anti-CD20 therapies after natalizumab
    Cunha, Carolina
    Matos, Sara
    Carvalho, Ines V.
    Cardoso, Joao
    Campelo, Isabel
    Feio, Jose
    Batista, Sonia
    Nunes, Carla
    Macario, Maria do Carmo
    Sousa, Livia Maria
    Correia, Ines
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 623 - 623
  • [32] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
  • [33] Dental Adverse Effects of Anti-CD20 Therapies
    Bartak, Helene
    Fareh, Tasnim
    Ben Othman, Nouha
    Viard, Delphine
    Cohen, Mikael
    Rocher, Fanny
    Ewig, Elliot
    Drici, Milou-Daniel
    Lebrun-Frenay, Christine
    NEUROLOGY AND THERAPY, 2024, 13 (03) : 917 - 930
  • [34] Anti-CD20 monoclonal antibody in autoimmune diseases
    Pogliani, EM
    Larocca, A
    BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (07) : 350 - 351
  • [35] Ofatumumab, a human anti-CD20 monoclonal antibody
    Osterborg, Anders
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 439 - 449
  • [36] Anti-CD20 antibody wows in multiple sclerosis
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2015, 33 (12) : 1215 - 1216
  • [37] Mechanisms of killing by anti-CD20 monoclonal antibodies
    Glennie, Martin J.
    French, Ruth R.
    Cragg, Mark S.
    Taylor, Ronald P.
    MOLECULAR IMMUNOLOGY, 2007, 44 (16) : 3823 - 3837
  • [38] Longterm clinical and immunological effects of Anti-CD20 treatment in patients with refractory systemic lupus erythematosus
    Lindholm, Catharina
    Boerjesson-Asp, Katharina
    Zendjanchi, Kiandokht
    Sundqvist, Anna-Carin
    Tarkowski, Andrej
    Bokarewa, Maria
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 826 - 833
  • [39] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
    Tokunaga, Mikiko
    Saito, Kazuyoshi
    Kawabata, Daisuke
    Imura, Yoshitaka
    Fujii, Takao
    Nakayamada, Shingo
    Tsujimura, Shizuyo
    Nawata, Masao
    Iwata, Shigeru
    Azuma, Taeko
    Mimori, Tsuneyo
    Tanaka, Yoshiya
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 470 - 475
  • [40] Anti-CD20 monoclonal antibodies: reviewing a revolution
    Casan, J. M. L.
    Wong, J.
    Northcott, M. J.
    Opat, S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2820 - 2841